metformin has been researched along with transforming growth factor beta in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (3.92) | 29.6817 |
2010's | 30 (58.82) | 24.3611 |
2020's | 19 (37.25) | 2.80 |
Authors | Studies |
---|---|
Choudhury, GG; Feliers, D; Foretz, M; Kasinath, BS; Lee, MJ; Mahimainathan, L; Mariappan, MM; Musi, N; Sataranatarajan, K; Viollet, B; Weinberg, JM | 1 |
Kanazawa, I; Sugimoto, T; Yamaguchi, T; Yamauchi, M; Yano, S | 1 |
Cufí, S; Joven, J; Martin-Castillo, B; Menendez, JA; Oliveras-Ferraros, C; Vazquez-Martin, A | 1 |
Ishibashi, Y; Matsui, T; Takeuchi, M; Yamagishi, S | 1 |
Chang, JW; Kim, JH; Kim, JS; Kim, SB; Lee, JH; Lee, SK; Park, JS | 1 |
Baines, DL; Baker, EH; Garnett, JP; Gill, S; Knight, GM; Lindsay, JA; Naik, S; Tregoning, JS | 1 |
Chung, RT; Fusco, DN; Goto, K; Jilg, N; Kato, N; Lin, W; Peng, LF; Schaefer, EA; Shao, RX; Zhang, L; Zhao, H | 1 |
Gao, Q; Shen, S; Wang, Y; Xia, Yj; Yi, L; Zhang, C; Zhang, X | 1 |
Han, B; Ma, Q; Qi, M; Shen, C; Wang, L; Xia, P; Yang, M; Zhang, J | 1 |
Chung, YM; Han, S; Kim, BH; Lee, H; Lee, HG; Park, CH; Shin, K; Ye, SK | 1 |
Chen, Z; Duan, Z; Fu, R; Gui, B; Jia, L; Li, M; Lu, J; Lv, Z; Shi, J; Tian, L; Yang, Y; Yao, G | 1 |
Choi, YK; Jang, SY; Jeon, JH; Jeong, WI; Jung, GS; Kang, YN; Kim, MK; Lee, IK; Park, KG; Park, SY; Shin, EC | 1 |
Chen, H; Han, R; He, Y; Huang, W; Li, K; Li, L; Lin, C; Lu, C; Sun, F; Wang, Y; Zhang, K | 1 |
Babykutty, S; Chen, I; Chin, SM; Deshpande, V; Fukumura, D; Hato, T; Incio, J; Jain, RK; Liu, H; Suboj, P; Vardam-Kaur, T | 1 |
Gan, X; Lu, L; Miao, N; Shen, Y; Xu, D; Xu, J; Xue, H; Zhang, W; Zhou, L | 1 |
Edgerton, SM; Fan, Z; Harrell, JC; Liu, B; Thor, AD; Wahdan-Alaswad, R | 1 |
Ebata, T; Ishiwata, T; Iwama, A; Iwasawa, S; Koide, S; Kurimoto, R; Sekine, I; Tada, Y; Takiguchi, Y; Tatsumi, K | 1 |
Araya, J; Fujita, Y; Hara, H; Hashimoto, M; Ito, S; Kadota, T; Kaneko, Y; Kobayashi, K; Kohrogi, H; Kojima, J; Kurita, Y; Kuwano, K; Minagawa, S; Morikawa, T; Nakayama, K; Numata, T; Odaka, M; Saito, N; Sato, N; Takasaka, N; Tsubouchi, K; Utsumi, H; Wakui, H; Yanagisawa, H; Yoshida, M | 1 |
Fushida, S; Harada, S; Hayashi, H; Kinoshita, J; Makino, I; Miyashita, T; Nakanuma, S; Nakayama, A; Ninomiya, I; Ohta, T; Okamoto, K; Oyama, K; Sakai, S; Tajima, H; Takamura, H; Tsukada, T | 1 |
Bajgelman, MC; Borin, TF; de Campos Zuccari, DA; de Carvalho Ferreira, L; Leonel, C; Moschetta, MG; Viloria-Petit, AM | 1 |
Ch'ang, HJ; Chang, TM; Chang, VH; Chen, SL; Peng, SL; Tsai, YC; Tsai, YL; Yu, WC | 1 |
Chen, N; Deng, X; Li, R; Li, Y; Luo, M; Luo, Y; Mu, L; Ren, M; Tan, X; Wan, Q; Wang, L; Wu, J | 1 |
Boehm, M; Hallenbeck, J; Hollander, MC; Ishii, H; Latour, LL; Lin, PC; Merchant, AS; Min, Y; Munasinghe, J; Ray-Choudhury, A; Xiao, Z; Yang, D; Yang, L | 1 |
Chen, X; Jiang, K; Shao, J; Shen, Z; Wu, P; Xu, A; Yang, X; Zheng, G | 1 |
Du, C; Liu, Y; Luo, F; Wang, Y; Zhang, N; Zhao, M | 1 |
Hu, L; Wang, Y; Wu, Z | 1 |
Byeon, HJ; Cho, J; Choi, WH; Han, SY; Kang, JW; Kim, CS; Kim, JM; Kim, JY; Lee, EJ; Lee, WJ; Lee, YS; Oh, SH; Yoo, BR; Yoo, H | 1 |
Admasu, TD; Barardo, D; Cazenave-Gassiot, A; Chaithanya Batchu, K; Gruber, J; Lam, VYM; Ng, LF; Tolwinski, NS; Wenk, MR; Xiao, L | 1 |
Shen, X; Xie, Y; Yan, S; Ye, J; Zheng, L | 1 |
Chenhong, L; Dan, L; Jianfei, C; Jianlong, G; Yan, S; Yong, C | 1 |
Culig, Z | 1 |
Jang, H; Kim, A; Kim, H; Kim, MJ; Kim, YH; Lee, SB; Lee, SJ; Myung, JK; Park, EH; Park, JH; Park, S; Shim, S | 1 |
Evans, R; Fissell, WH; Harris, R; Humes, HD; Love, H; Roy, S; Wilson, M; Zent, R | 1 |
Abdallah, HI; Ali, EMT; El-Sayed, SM | 1 |
Barathidasan, R; Malarvizhi, R; Mani, S; Sekar, V; Vasanthi, HR | 1 |
An, G; Jing, X; Lei, J; Li, W; Luo, M; Meng, D; Ning, Q; Shao, S; Zhang, L; Zhao, L; Zhao, X | 1 |
Ahn, HM; Jeon, HB; Lee, JH; Lee, WJ; Roh, H; Roh, TS; Yun, CO | 1 |
Chen, K; Hua, F; Jin, Z; Kc, R; Liu, J; Nicolas, YSM; Song, Z; Sun, J; Wang, H; Wu, T; Zhang, M | 1 |
Hua, Z; Wei, P | 1 |
Dong, X; Jin, X | 1 |
Liu, J; Shu, G; Xiao, J; Xiao, Q; Yin, G | 1 |
Baeri, A; Balaguer, T; Bellusci, S; Camuzard, O; Cegarra-Escolano, M; Diazzi, S; Fassy, J; Levraut, M; Mari, B; Ploumellec, MA; Rezzonico, R; Vassaux, G | 1 |
Allwood, BW; Chiyaka, TL; Kleyhans, L; Moodley, S; Naidoo, CC; Segal, LN; Singh, S; Theron, G | 1 |
Mandape, SN; Olokpa, E; Pratap, S; Stewart, MV | 1 |
Blanco-Acevedo, C; Castaño, JP; Doval-Rosa, C; Fuentes-Fayos, AC; G-García, ME; Gahete, MD; Jiménez-Vacas, JM; López, M; Luque, RM; Martín-Colom, J; Montero-Hidalgo, AJ; Ortega-Salas, RM; Peralbo-Santaella, E; Pérez-Gómez, JM; Sánchez-Sánchez, R; Solivera, J; Tena-Sempere, M; Toledano-Delgado, Á; Torres, E | 1 |
Bae, HB; Bom, JS; Choi, JI; Jeong, S; Kim, J; Yin, M | 1 |
Ali, HS; El-Adl, MA; El-Shafei, RA; Nomier, Y | 1 |
Chen, H; Chen, Q; Chu, L; Liu, Y; Ou, X; Yang, J; Zhou, Z; Zou, Q | 1 |
Dolcet, X; Egea, J; Encinas, M; Matias-Guiu, X; Navaridas, R; Nicholson-Sabaté, N; Perramon-Güell, A; Ruiz-Mitjana, A; Vidal-Sabanés, M; Yeramian, A | 1 |
Morshed, N; Reza, MS; Reza, R; Samdani, MN | 1 |
Alcalde-Estévez, E; Castillo, C; Castro, A; Costa, IG; Fernández, L; Herrero, JI; Jansen, J; Kramann, R; Lamas, S; Miguel, V; Nagai, J; Ranz, I; Reimer, KC; Rey-Serra, C; Rodríguez González-Moro, JM; Sancho, D; Sevilla, L; Sirera, B; Tituaña, J | 1 |
3 review(s) available for metformin and transforming growth factor beta
Article | Year |
---|---|
Epithelial mesenchymal transition and resistance in endocrine-related cancers.
Topics: Benzopyrans; Breast Neoplasms; Cadherins; Cell Plasticity; Cytokines; Disease Progression; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Female; Humans; Inflammation; Male; MAP Kinase Kinase 5; Metformin; MicroRNAs; Prostatic Neoplasms; Proto-Oncogene Proteins c-fos; Receptor, ErbB-2; Signal Transduction; Transforming Growth Factor beta | 2019 |
Immunologic and imaging signatures in post tuberculosis lung disease.
Topics: Biomarkers; Collagen; Complex Mixtures; Cytokines; Doxycycline; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung; Lung Diseases; Metformin; Mycobacterium tuberculosis; Peptide Hydrolases; Transforming Growth Factor beta; Tuberculosis | 2022 |
The effects of metformin on anti-Müllerian hormone levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Topics: Anti-Mullerian Hormone; Databases, Factual; Female; Humans; Metformin; Polycystic Ovary Syndrome; PubMed; Transforming Growth Factor beta | 2023 |
48 other study(ies) available for metformin and transforming growth factor beta
Article | Year |
---|---|
A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Carrier Proteins; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucose; Hypertrophy; Intracellular Signaling Peptides and Proteins; Kidney; Metformin; Multienzyme Complexes; Phosphoproteins; Protein Serine-Threonine Kinases; Rats; Ribonucleosides; Transforming Growth Factor beta | 2007 |
Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression.
Topics: Adenylate Kinase; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcification, Physiologic; Cell Differentiation; Metformin; Mice; Nitric Oxide Synthase Type III; Osteoblasts; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta | 2008 |
Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.
Topics: Animals; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cellular Senescence; Dogs; Epithelial-Mesenchymal Transition; Female; Fibrosis; Humans; Hypoglycemic Agents; Metformin; Neoplastic Stem Cells; Signal Transduction; Transforming Growth Factor beta | 2010 |
Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Topics: AMP-Activated Protein Kinases; Apoptosis; Cells, Cultured; Chemokine CCL2; Diabetic Nephropathies; DNA Fragmentation; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Kidney Tubules, Proximal; Metformin; Molecular Targeted Therapy; Osmolar Concentration; Protein Kinase Inhibitors; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic; RNA, Messenger; Transforming Growth Factor beta; Up-Regulation | 2012 |
AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition.
Topics: Albumins; Aldosterone; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Angiotensin II; Cell Line; Epithelial-Mesenchymal Transition; Glucose; Heme Oxygenase-1; Humans; Metformin; NADPH Oxidase 4; NADPH Oxidases; Nephrosclerosis; Pyrazoles; Pyrimidines; Reactive Oxygen Species; Ribonucleosides; Thioredoxins; Transforming Growth Factor beta | 2013 |
Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose.
Topics: Animals; Bacterial Load; Blood Glucose; Bronchoalveolar Lavage Fluid; Cells, Cultured; Chemokine CXCL9; Epithelial Cells; Granulocyte-Macrophage Colony-Stimulating Factor; Hyperglycemia; Interleukin-1alpha; Interleukin-6; Metformin; Mice; Mice, Inbred C57BL; Permeability; Pseudomonas aeruginosa; Receptors, Leptin; Respiratory System; Staphylococcus aureus; Transforming Growth Factor beta | 2013 |
The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.
Topics: Biopsy; Cell Line; Gene Expression Regulation; Hepacivirus; Hepatitis C; Humans; Liver; Metformin; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; RNA, Small Interfering; Signal Transduction; Transforming Growth Factor beta; Virus Replication | 2013 |
Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
Topics: Animals; Dehydroepiandrosterone; Female; Fibrosis; Hypoglycemic Agents; Hypolipidemic Agents; Metformin; Ovarian Diseases; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Simvastatin; Transforming Growth Factor beta; Uterine Diseases | 2013 |
Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
Topics: Antigens, CD; beta Catenin; Cadherins; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Hypoglycemic Agents; Luciferases; Male; Metformin; MicroRNAs; Prostate; Prostatectomy; Prostatic Neoplasms; RNA, Messenger; Signal Transduction; SOXC Transcription Factors; Transforming Growth Factor beta | 2014 |
Metformin enhances the anti-adipogenic effects of atorvastatin via modulation of STAT3 and TGF-β/Smad3 signaling.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Atorvastatin; Cell Differentiation; Cell Survival; Cyclin D1; Heptanoic Acids; Homeostasis; Hypoglycemic Agents; Kruppel-Like Transcription Factors; Metformin; Mice; Pyrroles; Signal Transduction; Smad3 Protein; Smad7 Protein; STAT3 Transcription Factor; Transforming Growth Factor beta; Tumor Suppressor Protein p53 | 2015 |
Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts.
Topics: Animals; Collagen Type I; Connective Tissue Growth Factor; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Fibroblasts; Hypoglycemic Agents; Kidney; Metformin; Mice; Mice, Inbred BALB C; Phosphorylation; Primary Cell Culture; RNA, Small Interfering; Smad3 Protein; Transforming Growth Factor beta | 2015 |
Small heterodimer partner attenuates profibrogenic features of hepatitis C virus-infected cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Cell Line, Tumor; Gluconeogenesis; Hepacivirus; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Metformin; Receptors, Cytoplasmic and Nuclear; Ribonucleotides; Signal Transduction; Transforming Growth Factor beta | 2015 |
Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway.
Topics: Animals; Antineoplastic Agents; Bleomycin; Blotting, Western; Epithelial-Mesenchymal Transition; Flow Cytometry; Gefitinib; Humans; Immunohistochemistry; Lung Diseases, Interstitial; Male; Metformin; Pulmonary Fibrosis; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Transforming Growth Factor beta | 2015 |
Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.
Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Interleukin-1beta; Macrophages; Male; Metformin; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Pancreatic Stellate Cells; Prognosis; STAT3 Transcription Factor; Transforming Growth Factor beta | 2015 |
Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts.
Topics: Angiotensin II; Animals; Disease Models, Animal; Extracellular Matrix Proteins; Fibroblasts; Gene Expression Regulation; Kidney Diseases; MAP Kinase Signaling System; Metformin; Mice; Transforming Growth Factor beta; Ureteral Obstruction | 2016 |
Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
Topics: Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Claudins; Disease-Free Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Humans; Mesenchymal Stem Cells; Metformin; Neoplasm Invasiveness; Prognosis; Protein Kinase Inhibitors; RNA, Messenger; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Triple Negative Breast Neoplasms; Up-Regulation | 2016 |
Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; B7-H1 Antigen; Cell Line, Tumor; Cell Survival; Cisplatin; Dimethyl Sulfoxide; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Fibroblast Growth Factor 2; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Indoles; Lung Neoplasms; Metformin; Mutation; Purines; Quinazolines; Transforming Growth Factor beta | 2016 |
Metformin attenuates lung fibrosis development via NOX4 suppression.
Topics: AMP-Activated Protein Kinases; Animals; Bleomycin; Cell Differentiation; Cells, Cultured; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Idiopathic Pulmonary Fibrosis; Lung; Metformin; Mice, Inbred C57BL; Myofibroblasts; NADPH Oxidase 4; Phosphorylation; Reactive Oxygen Species; RNA Interference; Smad Proteins; Time Factors; Transfection; Transforming Growth Factor beta | 2016 |
Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma.
Topics: Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Adhesion; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Metformin; Neoplasm Invasiveness; Phenotype; Phosphorylation; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Tumor Cells, Cultured; X-Rays | 2016 |
Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model.
Topics: Animals; Cadherins; Cell Line, Tumor; Cell Movement; Dogs; Epithelial-Mesenchymal Transition; Mammary Neoplasms, Animal; Metformin; Neoplasm Invasiveness; Transforming Growth Factor beta | 2017 |
Krüpple-like factor 10 regulates radio-sensitivity of pancreatic cancer via UV radiation resistance-associated gene.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Cell Line, Tumor; DNA Repair; Early Growth Response Transcription Factors; Humans; Kruppel-Like Transcription Factors; Metformin; Mice; Pancreatic Neoplasms; Radiation Tolerance; Transforming Growth Factor beta | 2017 |
MiRNA-21 mediates the antiangiogenic activity of metformin through targeting PTEN and SMAD7 expression and PI3K/AKT pathway.
Topics: 3' Untranslated Regions; Angiogenesis Inhibitors; Cell Movement; Cell Proliferation; Computational Biology; Gene Expression Regulation; Genes, Reporter; Human Umbilical Vein Endothelial Cells; Humans; Luciferases; Metformin; MicroRNAs; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Smad7 Protein; Transforming Growth Factor beta | 2017 |
Attenuation of Myeloid-Specific TGFβ Signaling Induces Inflammatory Cerebrovascular Disease and Stroke.
Topics: Animals; Cell Line; Immunosuppressive Agents; Inflammation; Metformin; Methotrexate; Mice; Mice, Inbred C57BL; Myeloid Cells; NF-kappa B; Penetrance; Signal Transduction; Stroke; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2017 |
Synergistic Chemopreventive and Therapeutic Effects of Co-drug UA-Met: Implication in Tumor Metastasis.
Topics: Animals; Cadherins; Cell Line, Tumor; Drug Synergism; Female; Humans; Metformin; Mice; Neoplasm Metastasis; Neoplasms; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Triterpenes; Ursolic Acid; Vimentin; Xenograft Model Antitumor Assays | 2017 |
Aspirin and metformin exhibit antitumor activity in murine breast cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspirin; Breast Neoplasms; Cell Proliferation; Female; Humans; Hypoglycemic Agents; Metformin; Mice; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Transforming Growth Factor beta; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC).
Topics: Cell Movement; Cell Proliferation; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; HCT116 Cells; Humans; Metformin; MicroRNAs; Neoplasm Invasiveness; Snail Family Transcription Factors; Transforming Growth Factor beta; Zinc Finger E-box-Binding Homeobox 1 | 2018 |
Metformin Alleviates Radiation-Induced Skin Fibrosis via the Downregulation of FOXO3.
Topics: Animals; Cells, Cultured; Class Ia Phosphatidylinositol 3-Kinase; Down-Regulation; Fibroblasts; Fibrosis; Forkhead Box Protein O3; Metformin; Mice; Mice, Inbred C57BL; NIH 3T3 Cells; Oxidative Stress; Radiation Injuries, Experimental; Radiation, Ionizing; RNA Interference; RNA, Small Interfering; Skin; STAT3 Transcription Factor; Transforming Growth Factor beta; Tumor Suppressor Protein p53 | 2018 |
Drug Synergy Slows Aging and Improves Healthspan through IGF and SREBP Lipid Signaling.
Topics: Aging; Allantoin; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Drosophila melanogaster; Drug Synergism; Ficusin; Gene Expression Regulation; Gene Regulatory Networks; Insulin-Like Growth Factor I; Lipid Metabolism; Lipids; Longevity; Metformin; Rifampin; Signal Transduction; Sirolimus; Sterol Regulatory Element Binding Protein 1; Transcriptome; Transforming Growth Factor beta | 2018 |
Metformin alleviates hyperglycemia-induced apoptosis and differentiation suppression in osteoblasts through inhibiting the TLR4 signaling pathway.
Topics: Animals; Apoptosis; Bone Density; Bone Morphogenetic Protein 2; Cell Differentiation; Cell Line; Diabetes Mellitus, Experimental; Down-Regulation; Hyperglycemia; Hypoglycemic Agents; Male; Metformin; Mice; NF-kappa B; Osteoblasts; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Signal Transduction; Toll-Like Receptor 4; Transforming Growth Factor beta; Up-Regulation | 2019 |
[Efficacy and safety of metformin for Behcet's disease and its effect on Treg/Th17 balance: a single-blinded, before-after study].
Topics: Behcet Syndrome; Controlled Before-After Studies; Forkhead Transcription Factors; Humans; Immunosuppressive Agents; Interleukin-17; Interleukins; Metformin; Neoplasm Recurrence, Local; Nuclear Receptor Subfamily 1, Group F, Member 3; Recurrence; RNA, Messenger; Single-Blind Method; T-Lymphocytes, Regulatory; Th17 Cells; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2019 |
Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemoradiotherapy; Colon; Colonic Neoplasms; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Fluorouracil; Humans; Male; Metformin; Mice; Mice, Nude; Neoplasm Recurrence, Local; Phenformin; Rectal Neoplasms; Signal Transduction; Smad Proteins; STAT3 Transcription Factor; Transforming Growth Factor beta; Xenograft Model Antitumor Assays | 2019 |
Metformin and Inhibition of Transforming Growth Factor-Beta Stimulate
Topics: Cells, Cultured; Humans; Kidney Tubules; Metformin; Receptor, Transforming Growth Factor-beta Type I; Transforming Growth Factor beta | 2020 |
Histomorphological, VEGF and TGF-β immunoexpression changes in the diabetic rats' ovary and the potential amelioration following treatment with metformin and insulin.
Topics: Animals; Diabetes Mellitus, Experimental; Down-Regulation; Female; Hypoglycemic Agents; Immunohistochemistry; Insulin; Metformin; Ovary; Rats; Transforming Growth Factor beta; Up-Regulation; Vascular Endothelial Growth Factor A | 2020 |
Positive interaction of mangiferin with selected oral hypoglycemic drugs: a therapeutic strategy to alleviate diabetic nephropathy in experimental rats.
Topics: Animals; Antioxidants; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Gliclazide; Hypoglycemic Agents; Kidney; Kidney Function Tests; Male; Metformin; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Xanthones | 2020 |
Metformin suppresses HIF-1α expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer.
Topics: Adenylate Kinase; Breast Neoplasms; Cancer-Associated Fibroblasts; Cell Line, Tumor; Chemokine CXCL12; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-8; MCF-7 Cells; Metformin; Neoplasm Invasiveness; Prolyl Hydroxylases; Signal Transduction; Transforming Growth Factor beta; Tumor Microenvironment; Up-Regulation | 2020 |
Metformin Inhibits Transforming Growth Factor β-Induced Fibrogenic Response of Human Dermal Fibroblasts and Suppresses Fibrosis in Keloid Spheroids.
Topics: Cells, Cultured; Fibroblasts; Fibrosis; Humans; Keloid; Metformin; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2021 |
Metformin attenuates post-epidural fibrosis by inhibiting the TGF-β1/Smad3 and HMGB1/TLR4 signaling pathways.
Topics: Animals; Failed Back Surgery Syndrome; Fibrosis; HMGB1 Protein; Humans; Male; Metformin; Mice; Mice, Inbred C57BL; NIH 3T3 Cells; Signal Transduction; Smad3 Protein; Toll-Like Receptor 4; Transforming Growth Factor beta | 2021 |
Letter to the Editor: Comment on Jeon HB, et al. Metformin Inhibits Transforming Growth Factor β-Induced Fibrogenic Response of Human Dermal Fibroblasts and Suppresses Fibrosis in Keloid Spheroids ( Ann Plast Surg . 2021;86:406-411).
Topics: Cells, Cultured; Fibroblasts; Fibrosis; Humans; Keloid; Metformin; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2022 |
Letter to the Editor: Comment on Jeon HB, et al. Metformin Inhibits Transforming Growth Factor β-Induced Fibrogenic Response of Human Dermal Fibroblasts and Suppresses Fibrosis in Keloid Spheroids ( Ann Plast Surg . 2021;86:406-411).
Topics: Cells, Cultured; Fibroblasts; Fibrosis; Humans; Keloid; Metformin; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2022 |
Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-β/PI3K/AKT signaling transduction.
Topics: Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Metformin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Transforming Growth Factor beta | 2022 |
A role for metformin in the treatment of Dupuytren disease?
Topics: Cells, Cultured; Dupuytren Contracture; Fibroblasts; Fibrosis; Humans; Metformin; Neoplasm Recurrence, Local; Transforming Growth Factor beta | 2022 |
Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells.
Topics: Androgens; Castration; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glucose; Humans; Insulins; Male; Metformin; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; RNA, Messenger; TOR Serine-Threonine Kinases; Transforming Growth Factor beta; Tumor Suppressor Protein p53; Wnt Signaling Pathway | 2022 |
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Mice; Proto-Oncogene Proteins c-akt; Retrospective Studies; Simvastatin; Transforming Growth Factor beta | 2023 |
AMPK reduces macrophage endotoxin tolerance through inhibition of TGF-β1 production and its signaling pathway.
Topics: AMP-Activated Protein Kinases; Animals; Endotoxin Tolerance; Interleukin-6; Lipopolysaccharides; Macrophages; Metformin; Mice; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2023 |
Ameliorative effect of Arabic gum Acacia and mori extracts in streptozotocin-induced diabetic rats: implications of Cas-3 and TGF-β.
Topics: Acacia; Animals; Antioxidants; Blood Glucose; Caspase 3; Diabetes Mellitus, Experimental; Gum Arabic; Hypoglycemic Agents; Metformin; Oxidative Stress; Plant Extracts; Rats; Streptozocin; Transforming Growth Factor beta | 2023 |
Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Diabetes Mellitus, Type 2; Endometrial Neoplasms; Female; Humans; Metformin; Mice; Transforming Growth Factor beta | 2023 |
Pharmacophore mapping approach to find anti-cancer phytochemicals with metformin-like activities against transforming growth factor (TGF)-beta receptor I kinase: An in silico study.
Topics: Diabetes Mellitus, Type 2; Humans; Ligands; Metformin; Molecular Docking Simulation; Molecular Dynamics Simulation; Neoplasms; Pharmacophore; Transforming Growth Factor beta | 2023 |
Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney.
Topics: AMP-Activated Protein Kinases; Animals; COVID-19; Fatty Acids; Fibrosis; Humans; Inflammation; Kidney; Lung; Metformin; Respiratory Distress Syndrome; Transforming Growth Factor beta | 2023 |